Related Experiment Video
Updated: Sep 5, 2025

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
Published on: May 30, 2012
PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM
Sayantani Sarkar Bhattacharya1,2,3, Prabhu Thirusangu1, Ling Jin1
1Department of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
Background:
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm and often acquires chemoresistance by increasing stemness in tumour tissue, thereby generating cancer stem cells (CSCs). CSCs escape treatment by deploying metabolic pathways to trigger dormancy or proliferation, also gaining the ability to exit and re-enter the cell cycle to hide their cellular identity.
Methods:
We employed various cellular and biochemical assays to identify the role of the glycolytic enzyme PFKFB3, by knocking it down and pharmacologically inhibiting it with PFK158, to determine its anticancer effects in vitro and in vivo by targeting the CSC population in MPM.
Results:
Here, we have identified PFKFB3 as a strategic player to target the CSC population in MPM and demonstrated that both pharmacologic (PFK158) and genetic inhibition of PFKFB3 destroy the FAK-Stat3-SOX2 nexus resulting in a decline in conspicuous stem cell markers viz. ALDH, CD133, CD44, SOX2. Inhibition of PFKFB3 accumulates p21 and p27 in the nucleus by decreasing SKP2. Lastly, PFK158 diminishes tumour-initiating cells (TICs) mediated MPM xenograft in vivo.
Conclusions:
This study confers a comprehensive and mechanistic function of PFKFB3 in CSC maintenance that may foster exceptional opportunities for targeted small molecule blockade of the TICs in MPM.
Insights
Targeting the glycolytic enzyme PFKFB3 with PFK158 effectively eliminates cancer stem cells (CSCs) in malignant pleural mesothelioma (MPM). This approach disrupts key stemness pathways, offering a new strategy against this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer often developing chemoresistance.
- Cancer stem cells (CSCs) contribute to chemoresistance by regulating stemness and cell cycle.
- Metabolic pathways in CSCs enable treatment evasion through dormancy or proliferation.
Purpose of the Study:
- To investigate the role of the glycolytic enzyme PFKFB3 in MPM.
- To evaluate the anticancer effects of PFKFB3 inhibition on CSCs in MPM.
- To explore PFKFB3 as a therapeutic target for MPM.
Main Methods:
- Utilized cellular and biochemical assays to study PFKFB3.
- Employed genetic knockdown and pharmacological inhibition (PFK158) of PFKFB3.
- Assessed in vitro and in vivo anticancer effects targeting CSCs in MPM models.
Main Results:
- PFKFB3 inhibition (genetic and PFK158) disrupted the FAK-Stat3-SOX2 nexus.
- Observed a decrease in stem cell markers (ALDH, CD133, CD44, SOX2) upon PFKFB3 inhibition.
- PFKFB3 inhibition led to nuclear accumulation of p21 and p27 by decreasing SKP2.
- PFK158 treatment reduced tumor-initiating cells (TICs) in vivo MPM xenografts.
Conclusions:
- PFKFB3 is a critical regulator of CSC maintenance in MPM.
- Targeting PFKFB3 with small molecules like PFK158 shows promise for blocking TICs in MPM.
- This study provides mechanistic insights for developing novel targeted therapies against MPM CSCs.
More Related Videos
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
Related Concept Videos
Master Transcription Regulators
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Somatic to iPS Cell Reprogramming
Stem Cell Niche
Methods of Nuclear Reprogramming